Mouse Tacstd2 Stable Cell Line - CHO-K1

The Tumor-Associated Calcium Signal Transducer 2 gene (commonly abbreviated as Tacstd2 or Trop-2) encodes a highly conserved Type I transmembrane glycoprotein that plays a pivotal role in a multitude of cellular processes and developmental mechanisms. In murine models, the mouse Tacstd2 gene is localized to chromosome 4 and is intricately involved in regulating cell proliferation, adhesion, migration, and survival. Structurally, the mouse Tacstd2 protein consists of a large extracellular domain containing epidermal growth factor (EGF)-like repeats, a single transmembrane domain, and a short intracellular tail harboring key signaling motifs. This intracellular tail is critical for downstream signal transduction—specifically, it mediates intracellular calcium release and activates the MAPK/ERK pathway, thereby ultimately driving cell growth and division. Although Tacstd2 is physiologically expressed in various epithelial tissues and adult stem cells to facilitate tissue regeneration and embryonic development, the gene has garnered significant attention due to its pathological overexpression across a wide spectrum of epithelial tumors. This overexpression is frequently and strongly correlated with heightened tumor invasiveness, enhanced metastatic potential, and poor clinical prognosis. Given its prominent localization on the cell surface and its differential expression between normal and malignant tissues, the Tacstd2 gene product has emerged as a premier biomarker in contemporary oncology, as well as a highly attractive therapeutic target.

The mouse Tacstd2 stable cell line, established using CHO-K1 host cells, serves as a highly specialized and indispensable tool for in vitro research. This product was generated by stably transfecting the full-length mouse Tacstd2 gene into Chinese Hamster Ovary (CHO-K1) cells, followed by rigorous antibiotic selection and clonal isolation procedures to ensure uniform, high-level, and sustained expression of the mouse Tacstd2 protein on the cell surface. The Mouse Tacstd2 Stable Cell Line (CHO-K1) serves as a reliable immunogen and high-throughput screening platform for the discovery and development of novel monoclonal antibodies, bispecific antibodies, and antibody-drug conjugates targeting the mouse Tacstd2 antigen. Researchers rely heavily on these stable cell lines to conduct comprehensive binding analyses—including flow cytometry and immunocytochemistry—in order to assess the affinity and specificity of candidate therapeutics. Furthermore, this cell line is critical for conducting cross-reactivity studies; it enables scientists to evaluate whether therapies designed against human Trop-2 can also recognize its mouse homolog—an essential step prior to initiating in vivo safety and efficacy trials in mouse models.